نتائج البحث

Real‐world first‐line treatment with pembrolizumab for non‐small cell lung carcinoma with high PD‐L1 expression: Updated analysis.

• Authors : Ikezawa, Yasuyuki^1,2 (AUTHOR) ; Morita, Ryo³ (AUTHOR) ; Mizugaki, Hidenori^4,5 (AUTHOR)

• Source: Cancer Medicine. Jul2024, Vol. 13 Issue 14, p1-11. 11p.

تفاصيل العنوان

Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage–Myofibroblast Transition in Non‐Small‐Cell Lung Carcinoma.

• Authors : Tang, Philip Chiu‐Tsun¹ (AUTHOR); Chan, Max Kam‐Kwan¹ (AUTHOR); Chung, Jeff Yat‐Fai¹ (AUTHOR)

• Source: Advanced Science. 1/5/2024, Vol. 11 Issue 1, p1-14. 14p.

تفاصيل العنوان

A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) (TARGET)

• Source: An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following

تفاصيل العنوان

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival.

• Authors : Sakuma Y; Department of Molecular Medicine, Research Institute for Immunology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.; Hirai S

Subjects: Kinesins*/Kinesins*/Kinesins*/metabolism ; Kinesins*/Kinesins*/Kinesins*/genetics ; Kinesins*/Kinesins*/Kinesins*/antagonists & inhibitors

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 30; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Small cell lung carcinoma presenting initially with recurrent pneumothoraces: a case report.

• Authors : Buchanan J; University of Birmingham Medical School, Edgbaston, Birmingham, B15 2TT, West Midlands, UK.; Shatila M

Subjects: Pneumothorax*/Pneumothorax*/Pneumothorax*/etiology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnosis

• Source: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Jun 21; Vol. 19 (1), pp. 347. Date of Electronic Publication: 2024 Jun 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101265113 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-8090

تفاصيل العنوان

Discordant ALK Status in Non-Small Cell Lung Carcinoma: A Detailed Reevaluation Comparing IHC, FISH, and NGS Analyses.

• Authors : Tobiášová, Katarína¹ (AUTHOR) ; Barthová, Martina¹ (AUTHOR); Janáková, Ľuboslava¹ (AUTHOR)

• Source: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8168. 19p.

تفاصيل العنوان

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

• Authors : AstraZeneca; Celgene Corporation; Merck Sharp & Dohme LLC

• Source: Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung

تفاصيل العنوان

A combined small cell lung carcinoma patient with only small cell carcinoma components in mediastinal lymph node metastasis and chondrosarcoma‐like components in liver metastasis.

• Authors : Kawaguchi, Takako¹ (AUTHOR); Yamasaki, Kei¹ (AUTHOR) ; Shigemi, Saki¹ (AUTHOR)

• Source: Respirology Case Reports. Jun2024, Vol. 12 Issue 6, p1-5. 5p.

تفاصيل العنوان

Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.

• Authors : Dinić, Jelena¹ (AUTHOR) ; Podolski-Renić, Ana¹ (AUTHOR) ; Dragoj, Miodrag¹ (AUTHOR)

• Source: Diagnostics (2075-4418). Dec2023, Vol. 13 Issue 24, p3617. 18p.

تفاصيل العنوان

Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma

• Authors : Clovis Oncology, Inc.; Zhonglin Hao, Professor

• Source: Phase II Study of Combination Rucaparib With Nivolumab in Platinum-Sensitive Small Cell Lung

تفاصيل العنوان